american society of anesthesiologists glp 1 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists Avery Fredman and Lourdes Hindi,

Factors associated with poor health-related quality of life of patients with cirrhosis

A.ZwartS

Pyridoxal 5'-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients

A) Once-daily long-acting insulin glargine (typically given at bedtime) achieves a steady-state within ~2 hours, does not display a distinct peak, and has a 20-24 hour duration of action in most patients

This raises doubts about relying solely on coconut oil for similar effects

Glucagon-Like Peptide 1 Receptor Agonists and Vasospasm of Epicardial Coronary Arteries Spasms in the smooth muscle layer of the coronary artery wall can be focal or diffuse, resulting in vasospastic angina or myocardial infarction (MI), respectively